1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Kairos Pharma, Ltd.

Kairos Pharma, Ltd.

KAPA
Kairos Pharma, Ltd.US flagNew York Stock Exchange American
0.36
USD
+0.04
- -
7.67MMarket Cap

Income Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
2
1
2
2
6
+ Selling, General & Admin
1
2
- -
1
2
3
+ Research & Development
- -
- -
- -
- -
- -
2
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-2
-1
-2
-2
-6
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
- -
Pretax Income
-1
-2
-1
-2
-3
-5
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-2
-1
-2
-3
-5
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-2
-1
-2
-3
-5
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-2
-1
-2
-3
-5
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-2
-1
-2
-3
-5
EBIT
-1
-2
-1
-2
-2
-6
EBITDA
-1
-2
- -
-2
-2
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
EBITA
-1
-2
-1
-2
-2
-6
Gross Margin (%)
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
11
11
11
11
11
18
Basic EPS, GAAP
-0.09
-0.2
-0.1
-0.16
-0.23
-0.3
Basic EPS from Cont Ops
-0.09
-0.2
-0.1
-0.16
-0.23
-0.3
Diluted Weighted Avg Shares
11
11
11
11
11
18
Diluted EPS, GAAP
-0.09
-0.2
-0.1
-0.16
-0.23
-0.3
Diluted EPS from Cont Ops
-0.09
-0.2
-0.1
-0.16
-0.23
-0.3

Balance Sheet (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
- -
- -
- -
4
5
+ Cash, Cash Equivalents & STI
- -
- -
- -
- -
1
4
+ Cash & Cash Equivalents
- -
- -
- -
- -
1
4
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
3
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
1
1
2
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
1
1
2
1
+ Total Intangible Assets
- -
1
1
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
1
1
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
1
1
Total Assets
- -
1
1
1
6
7
+ Payables & Accruals
- -
2
2
2
1
- -
+ Accounts Payable
- -
2
2
2
1
- -
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
- -
- -
- -
+ ST Debt
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
2
2
2
1
- -
+ LT Debt
- -
- -
1
1
- -
- -
+ LT Borrowings
- -
- -
1
1
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
1
1
- -
- -
Total Liabilities
- -
2
2
3
1
- -
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
2
3
4
14
21
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
2
3
4
14
21
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-1
-3
-4
-6
-9
-14
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
-1
-1
-2
5
6
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
- -
-1
-1
-2
5
6
Total Liabilities & Equity
- -
1
1
1
6
7
Shares Outstanding
13
13
13
13
14
21
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
Net Debt
- -
- -
- -
1
-1
-4
Net Debt to Equity
-10.41
-26.31
-12.3
-26.23
-26.63
-70.82
Tangible Common Equity Ratio
-2,396.13
-2,560.27
-348.38
-421.96
82.11
96.93
Current Ratio
0.04
0.04
0.27
0.04
4.2
27.07
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-1
-2
-1
-2
-3
-5
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
1
- -
- -
1
- -
3
+ Stock-Based Compensation
1
- -
- -
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
1
- -
3
+ Chg in Non-Cash Work Cap
- -
1
- -
1
-2
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
-2
- -
+ Inc (Dec) in Accts Payable
- -
1
- -
1
- -
-1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
- -
- -
- -
-4
-3
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
6
- -
+ Increase in Capital Stock
- -
- -
- -
- -
6
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
1
- -
- -
- -
+ Cash From Debt
- -
- -
1
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
1
1
- -
5
7
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
- -
1
3
EBITDA
-1
-2
- -
-2
-2
-5
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
- -
- -
- -
-4
-3
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
1
- -
-4
-3
Free Cash Flow per Basic Share
- -
-0.04
-0.03
0.01
-0.35
-0.19
Price/Free Cash Flow
- -
- -
- -
- -
-4.36
-3.8
Cash Flow to Net Income
0.04
0.19
0.34
-0.04
1.52
0.63
Capital Expenditures
- -
- -
- -
- -
- -
- -